Nada Fahd/LinkedIn
Jun 4, 2026, 16:17
Nada Fahd: Immune Thrombocytopenia (ITP) – Outpatient vs Inpatient Management
Nada Fahd, Lecturer of pediatrics at Suez Canal University, shared a post on LinkedIn:
“Immune Thrombocytopenia (ITP): Outpatient vs Inpatient Management
One of the most common questions in pediatric practice is deciding which children with ITP can be safely managed at home and which require hospitalization.
Consider Outpatient Management When:
- Platelet count greater than 10,000–20,000/μL
- Mild to moderate bleeding (petechiae, bruising)
- Hemodynamically stable
- No significant mucosal bleeding
- Reliable caregivers with easy access to medical care
Consider Hospitalization When:
- Platelet count less than 10,000/μL with mucosal or internal bleeding
- Life-threatening hemorrhage (e.g., intracranial bleeding)
- Hemodynamic instability
- Diagnostic uncertainty requiring exclusion of other serious conditions (e.g., leukemia, sepsis)
Remember:
The decision to admit should be guided not only by the platelet count but also by the severity of bleeding, clinical stability, and the ability to ensure close follow-up.”
Stay updated with Hemostasis Today.
-
Jul 21, 2026, 08:43Joy Duemke: Optimizing Stem Cell Collection for Gene Therapy Success
-
Jul 21, 2026, 07:55A New Era of Precision Imaging for Venous Thromboembolism – JTH
-
Jul 21, 2026, 07:43How to Monitor and Manage Unfractionated Heparin in Practice – JTH
-
Jul 21, 2026, 07:23Arthur Allen: Advancing Outpatient Antithrombotic Stewardship Through ADAPT
-
Jul 21, 2026, 03:19Where Does Stroke Treatment Go Next on The Latest ESOC 2026 TV Studio Session – ESO
-
Jul 21, 2026, 03:09Francesca Palandri: New Insights Into Anemia Management in Myelofibrosis
-
Jul 21, 2026, 01:57A New Approach to Understanding Plasmin Generation and Fibrinolysis – RPTH Journal
-
Jul 21, 2026, 01:52Maria Diaz Alonso: Delivering My First International Oral Presentation at ISTH 2026
-
Jul 21, 2026, 01:44Megan Preece: Presenting New Research on Antiphospholipid Syndrome at ISTH 2026